Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-16

Clinical Trial Update: Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of photodynamic therapy with Levulan Kerastick and blue light for actinic keratoses on the upper extremities comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levulan Kerastick + Blue Light (5-aminolevulinic acid (topical))

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2015-09-16